Date published: 2025-10-30

00800 4573 8000

SCBT Portrait Logo
Seach Input

TBC1D22A Ativadores

TBC1D22A is a protein encoded by the TBC1D22A gene in humans. Its name reflects its classification: TBC1 indicates that it contains a TBC (Tre-2, Bub2, and Cdc16) domain, which is typically associated with proteins that have GTPase-activating protein (GAP) activity towards small GTPases of the Rab family. The 'D22A' suffix denotes its specific gene identifier within this family.Proteins in this group, including TBC1D22A, are regulators of intracellular vesicle trafficking. They function by inactivating Rab GTPases, which play critical roles in directing vesicle transport along cytoskeletal tracks to different cellular compartments such as the Golgi apparatus, endosomes, lysosomes, and the plasma membrane. By acting as GAPs, TBC domain-containing proteins like TBC1D22A help control the timing of vesicle fusion and release, ensuring that cargo is delivered to the correct location within the cell.

The TBC1D22A protein may have specific substrates among the Rab GTPases, although the precise Rab targets and the pathways that TBC1D22A regulates are not well-characterized compared to other members of the TBC domain-containing protein family. It is likely involved in processes such as membrane trafficking, signal transduction, and cellular growth and differentiation.Mutations or dysregulation of proteins that control vesicle trafficking, like TBC1D22A, can lead to a wide array of cellular dysfunctions and are often implicated in diseases including neurological disorders, cancer, and metabolic syndromes.

VEJA TAMBÉM

Items 1 to 10 of 11 total

Mostrar:

Nome do ProdutoCAS #Numero de CatalogoQuantidadePrecoUso e aplicacaoNOTAS

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

A brefeldina A perturba a função do aparelho de Golgi e pode afetar indiretamente a atividade da Rab GTPase relacionada com a TBC1D22A.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

O nocodazol perturba a dinâmica dos microtúbulos, afectando o transporte vesicular e, potencialmente, a função da TBC1D22A.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

A forskolina, ao elevar os níveis de AMPc, pode modular várias vias de sinalização, influenciando possivelmente a TBC1D22A.

9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine

1380288-87-8sc-500607
50 mg
$13500.00
(0)

O ML141 é um inibidor da Cdc42, com potencial impacto nas vias que se cruzam com a atividade da Rab GTPase relacionada com o TBC1D22A.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$148.00
$597.00
75
(4)

O NSC23766 inibe a Rac1, o que pode ter efeitos a jusante nos processos celulares que envolvem a TBC1D22A.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$145.00
$442.00
64
(4)

A citocalasina D rompe os filamentos de actina, afectando a morfologia e o transporte celular, com potencial impacto na TBC1D22A.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A Wortmannin é um inibidor da PI3K, influenciando o tráfico de vesículas e possivelmente a função da TBC1D22A.

YM201636

371942-69-7sc-204193
5 mg
$213.00
6
(1)

O YM201636 inibe a PIKfyve, afectando o tráfico endossomal, potencialmente relevante para as actividades da TBC1D22A.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

O Dynasore inibe a dinamina, afectando a endocitose e o tráfico vesicular, potencialmente relevante para o TBC1D22A.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

A cloroquina, que afecta a função endossomal e lisossomal, pode ter implicações nos processos relacionados com o TBC1D22A.